AzTrials
AzTrials

Cesarean SectionNCT07729254

Association Between Cesarean Scar Mobility and Menstrual Pain in Post-Cesarean Women

An observational study of Cesarean Section and Dysmenorrhea, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this observational cross-sectional study is to investigate the association between cesarean scar mobility and menstrual pain severity in women following cesarean section. The study will enroll women aged 20 to 35 years with a history of cesarean delivery who experience menstrual pain. Read more about this study

Who is it for?
Ages 20 to 35 years, women only
Conditions the study is for
Cesarean Section, Dysmenorrhea
How many people
51 participants
Where
1 siteEgypt
Study dates
23 Jul 2026to 25 Aug 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 35 years
  • Women only
  • No healthy volunteers
  • Adult

Study population: Women aged 20-35 years with a previous cesarean section who experience menstrual pain.

Who may be able to join

  • Females aged 20-35 years.
  • History of at least one cesarean section.
  • Regular menstrual cycles.
  • Presence of menstrual pain during the previous three menstrual cycles.
  • Body mass index (BMI) between 18.5 and 29.9 kg/m².
  • Willingness to participate and provide written informed consent.

Who cannot join

  • Current pregnancy.
  • History of pelvic or abdominal surgery other than cesarean section.
  • Endometriosis or adenomyosis.
  • Uterine fibroids associated with pelvic pain.
  • Pelvic inflammatory disease.
  • Congenital uterine anomalies.
Show all 11Show fewer
  • Neurological disorders affecting pain perception.
  • Current use of hormonal therapy or medications affecting pain perception.
  • Active skin infection or open wound over the cesarean scar.
  • Malignancy.
  • Inability to complete study assessments.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Physical Therapy Outpatient Clinic

    Cairo

Other trials in Egypt

About this study

Official title: Association Between Cesarean Scar Mobility and Menstrual Pain Severity in Post-Cesarean Women: A Correlational Study

The aim of this observational cross-sectional study is to investigate the association between cesarean scar mobility and menstrual pain severity in women following cesarean section. The study will enroll women aged 20 to 35 years with a history of cesarean delivery who experience menstrual pain. Baseline assessments will be performed to evaluate cesarean scar mobility, menstrual pain severity, pressure pain threshold, and related clinical characteristics. The findings will help clarify whether reduced cesarean scar mobility is associated with greater menstrual pain severity and may provide evidence supporting the clinical assessment of cesarean scars in women with post-cesarean menstrual pain.

Read the detailed description

Cesarean section is one of the most frequently performed surgical procedures worldwide. Although generally safe, postoperative scar formation and fascial adhesions may result in long-term alterations in tissue mobility and biomechanics. These changes have been suggested to contribute to persistent symptoms, including menstrual pain, chronic pelvic pain, abdominal tenderness, and functional impairment. Despite increasing interest in cesarean scar assessment, the relationship between scar mobility and menstrual pain severity has not been sufficiently investigated.

Restricted scar mobility may influence the mechanical behavior of the abdominal wall and surrounding fascial structures, potentially contributing to altered force transmission, increased tissue sensitivity, and pain during menstruation. Understanding this relationship may improve the clinical evaluation of women presenting with post-cesarean menstrual pain and assist in identifying patients who may benefit from targeted rehabilitation interventions.

This observational cross-sectional study aims to investigate the association between cesarean scar mobility and menstrual pain severity in women following cesarean section. Baseline measurements will be obtained to assess cesarean scar mobility, menstrual pain severity, pressure pain threshold, and selected demographic and obstetric characteristics. Correlation and regression analyses will be performed to determine whether cesarean scar mobility is associated with menstrual pain severity and whether it independently predicts menstrual pain after controlling for potential confounding variables.

The findings of this study are expected to improve understanding of the clinical significance of cesarean scar mobility in women with menstrual pain and provide evidence to support comprehensive scar assessment as part of women's health physical therapy practice.

Keywords
Cesarean Scar, Scar Mobility, Dysmenorrhea, Menstrual Pain, Visual Analog Scale, Adheremeter, Pressure Pain Threshold, Post-Cesarean Women
Medical subject headings
Dysmenorrhea

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Menstrual Pain Severity

    Menstrual pain severity will be assessed using the 10-cm Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater menstrual pain severity.

    Measured: Baseline

  2. Cesarean Scar Mobility

    Cesarean scar mobility will be assessed using the Adheremeter. Higher scores indicate

    Measured: Baseline

Secondary outcomes (2)
  1. Pressure Pain Threshold

    Pressure pain threshold will be measured using a pressure algometer. Higher values indicate a higher pressure pain threshold.

    Measured: Baseline

  2. WaLIDD Score

    The severity of dysmenorrhea will also be evaluated using the Working ability, Location, Intensity, Days of pain, and Dysmenorrhea (WaLIDD) Score as a secondary clinical measure. The total score ranges from 0 to 12, with higher scores indicating more severe dysmenorrhea.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2026
  2. Study start23 Jul 2026
  3. Primary completion25 Aug 2026
  4. Study completion25 Aug 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
51 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07729254
Sponsor's protocol ID
P.T.REC/012/006453
Status last verified
Jul 2026
First submitted
22 Jul 2026
Last updated
16 Sep 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cesarean Section and Dysmenorrhea, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Menstrual Pain Severity (time frame: Baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in